Ionis Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Ionis Pharmaceuticals is scheduled to report earnings on May 1, 2024, and the estimated EPS forecast is $-1.01. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 324.50M	$ 144.21M	$ 110.51M	$ 130.52M	$ 151.89M
Gross Profit	$ 321.44M	$ 142.02M	$ 415.80M	$ -68.63M	$ 148.20M
EBIT	$ 1.79M	$ -136.60M	$ -75.16M	$ -95.82M	$ -38.61M
EBITDA	$ 579.00K	$ -137.23M	$ -75.43M	$ -93.77M	$ -31.58M
Net Income Common Stockholders	$ -1.35B	$ 301.03M	$ -85.29M	$ -124.32M	$ -52.43M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 2.33B	$ 2.24B	$ 2.39B	$ 2.35B	$ 1.99B
Total Assets	$ 2.99B	$ 2.93B	$ 2.97B	$ 2.89B	$ 2.53B
Total Debt	$ 257.04M	$ 173.04M	$ 175.02M	$ 185.81M	$ 1.37B
Net Debt	$ -2.07B	$ -2.06B	$ -2.21B	$ -2.16B	$ -617.67M
Total Liabilities	$ 2.60B	$ 2.62B	$ 2.54B	$ 2.40B	$ 1.96B
Stockholders Equity	$ 386.69M	$ 315.46M	$ 428.30M	$ 486.57M	$ 572.89M
Cash Flow	-
Free Cash Flow	$ 32.91M	$ -112.26M	$ -110.44M	$ -145.72M	$ -205.20M
Operating Cash Flow	$ 32.87M	$ -109.02M	$ -97.36M	$ -133.99M	$ -200.19M
Investing Cash Flow	$ -26.71M	$ 68.71M	$ 69.52M	$ -325.64M	$ 212.15M
Financing Cash Flow	$ 40.72M	$ -32.27M	$ 143.54M	$ 492.09M	$ -51.02M

Currency in USD

Ionis Pharmaceuticals Earnings and Revenue History

Income Statement >

Ionis Pharmaceuticals Debt to Assets

Balance Sheet >

Ionis Pharmaceuticals Cash Flow

Cash Flow >

Ionis Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing